Lumos Pharma - Rasio total nilai perusahaan marang pendapatan LUMO

Lumos Pharma Inc (LUMO) - logo korporat

Lumos Pharma, Inc. (LUMO) maintains a stable management team focused on obtaining regulatory approval for its key drug, a focus supported by the Enterprise Value-to-Revenue multiple. The value characterizes this specific valuation metric. Growth is driven by the development of oral growth hormone secretagogues for rare pathologies. The company's strategy is based on replacing painful injections with convenient tablets, which significantly improves patient adherence to therapy.

LUMO Lumos Pharma, Inc.: Rasio nilai perusahaan marang pendapatan ing interval 04.07.2022 - 20.11.2026

Rincian metrik keuangan lan pasar Lumos Pharma Inc (LUMO)

- rega saham lan prakiraan rega para ahli:
- indikator dhuwit lan arus kas:
Analisis wiwitan perusahaan:Lumos Pharma, Inc.
Barang unggulan Lumos Pharma

Professional selection of resilient assets requires comparing Enterprise Value (EV) with sales volume to determine the premium paid per unit of revenue regardless of debt load. By analyzing EV/Sales dynamics, an investor assesses the capitalization efficiency of Lumos Pharma, Inc. (LUMO) during the merger of R&D platforms, where cost optimization during the rollout of new drugs directly impacts the company's fundamental attractiveness.

Analisis pesaing

ASND: Rasio nilai perusahaan marang pendapatan|MDGL: Multiplikator EV/Sales|CORT - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Rhythm Corp|Akero Corp (AKRO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan metsera.com (MTSR)|Nilai perusahaan marang pendapatan moonlaketx.com MLTX|Multiplikator EV/Sales CRNX (Crinetics Pharmaceuticals, Inc.)|NAMS: Rasio nilai perusahaan marang pendapatan|SLNO - Rasio nilai perusahaan marang pendapatan|Amicus Pharma (FOLD) - Nilai perusahaan marang pendapatan|ETNB: Multiplikator EV/Sales|AGIO - Rasio total nilai perusahaan marang pendapatan|Nilai perusahaan marang pendapatan GPCR|Multiplikator nilai perusahaan marang pendapatan MiMedx MDXG|Rasio nilai perusahaan marang pendapatan Rezolute Corp (RZLT)|Nilai perusahaan marang pendapatan Lexicon Corp LXRX|Rasio nilai perusahaan marang pendapatan MBX Biosciences, Inc. MBX|Multiplikator EV/Sales altimmune.com ALT|AARD - Rasio nilai perusahaan marang pendapatan|Sagimet - Koefisien nilai perusahaan marang pendapatan|BioAge Labs Inc. (BIOA) - Rasio nilai perusahaan marang pendapatan|Nilai perusahaan marang volume dodolan BMEA (Biomea Fusion, Inc.)|QNCX (quincetx.com) - Multiplikator EV/Sales|GUTS: Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan vtvtherapeutics.com (VTVT)|ATPC (Agape ATP) - Nilai bisnis marang pendapatan|Rasio nilai perusahaan marang pendapatan Pluristem Therapeutics PLUR|SYBX: Rasio nilai perusahaan marang pendapatan|lipocine.com - Multiplikator EV/Sales|Nilai perusahaan marang volume dodolan MTNB|SPRB: Multiplikator EV/Sales|Rasio nilai perusahaan marang dodolan Galecto Inc GLTO|Rasio nilai perusahaan marang pendapatan Carmell Corp|Organovo Corp (ONVO) - Rasio total nilai perusahaan marang pendapatan|Rasio nilai perusahaan marang pendapatan Radius Recycling (RDUS)